March 8th 2023
In a recent study, the risk of death from respiratory diseases during adulthood almost doubled in individuals who experienced a lower respiratory tract infection at a young age.
November 8th 2022
FDA launches “Next Legend” e-cigarette prevention campaign for American indigenous youthJune 9th 2022
The FDA recently announced an e-cigarette prevention campaign aimed at Native American and Alaskan Native youth using prominent social media sites and traditional media like billboards, radio, and TV.
Pulse oximetry may fail to detect hypoxemia in Black kids more often than in White kidsApril 27th 2022
Previous investigation has shown that common measurements and tools may not be as accurate in non-White patients as they are in White patients. A new investigation dives into whether pulse oximetry falls into this category.
Which ELGANs are most at risk of low lung function?April 4th 2022
An investigation examines what demographic factors and less-than-optimal respiratory support in or beyond the neonatal intensive care unit can increase the risk of abnormal lunch function on extremely low gestational age newborns (ELGANs).
Comparing LABA plus inhaled corticosteroids to inhaled corticosteroids only for treating prematurity-associated lung diseaseDecember 15th 2021
Decreased lung function may be a result of a preterm delivery. Does treatment with long-acting β2 agonists (LABA) plus inhaled corticosteroids perform better than just inhaled corticosteroids to improve lung function in affected children?
Utilizing peer leaders to improve asthma management in teens living in urban areasDecember 9th 2021
In spite of the availability of effective treatments, asthma is not always well controlled among teenagers. An investigation examines whether using peers to helm education efforts can lead to improved outcomes.
Did FDA safety communications alter opioid cough medication prescription behaviors?November 16th 2021
An investigation examines whether safety communications from the US Food and Drug Administration (FDA) in 2017 and 2018 led to reductions in the prescription of cough and cold medications with codeine and hydrocodone.
Is it COVID-19 or CAP? A look at diagnostic decisions and treatments for 2021-2022October 18th 2021
Between the subtle differences between viral and bacterial pneumonia and the demands or beliefs of certain parents can make an accurate diagnosis of community-acquired pneumonia (CAP) more difficult.
Available biologics for treating asthma and allergic skin diseaseOctober 11th 2021
In cases of poorly controlled disease, even with good medication adherence, it might make sense to turn to biologics. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition covered biologics available for treating asthma and allergic skin disease.
It takes a village: community interventions to address teen e-cigarette useOctober 10th 2021
At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Maria Rahmandar, MD, FAAP, reviews issues surrounding teen e-cigarette use in schools, along with methods to help teens quit.
Medication nonadherence: What may cause it and how to prevent itOctober 10th 2021
Nonadherence to medication is a frustrating element of treating patients, particularly those with chronic conditions. A session at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition offers insight into the common causes behind it and how to improve adherence.